LL-37
LL-37 is the only known human cathelicidin antimicrobial peptide., wound healing and immune modulation.
Potency loss over time
Estimated potency retained (%) per storage condition. Hover the chart for details.
⚠ Estimates modelled per compound from its molecular properties (sequence length, cyclisation, oxidation- and deamidation-prone residues, light sensitivity). Indicative only — not lab-measured per batch.
Time in body
How much of a single dose remains over time, modelled from the terminal half-life. Illustrative — not a dosing tool.
Half-life ~1.0 h (animal PK) · effectively cleared (~97%) after ~5.0 h (5 half-lives).
Research context only — not dosing guidance. · Source: Preclinical ~1 h
| # | Suppliers | Price | €/mg | Price trend (6 months) | Purity | COA | Score ⓘ | |
|---|---|---|---|---|---|---|---|---|
| 1 |
 PRI
| €39.99 | €8.0/mg | ▼9.9% | 99% | ✔ COA | Shop → | |
| 2 |
 OME
| €39.99 | €8.0/mg | ▼4.5% | 99% | ✔ Third-party | Shop → | |
| 3 |
 RES
| €39.99 | €8.0/mg | 99.8% | ✔ HPLC/LC-MS | Shop → | ||
| 4 |
 24P
24PEPTIDES
in stock 🇳🇱 NL
| €59 | €11.8/mg | ▼1.2% | 99% | ✔ Liquilabs | Shop → | |
| 5 |
 PAR
PARTICLE PEPTIDES
in stock 🇸🇰 SK
| €79.99 | €16.0/mg | ▼3.2% | 99% | ✔ HPLC/LC-MS | Shop → |
Prices manually checked and updated monthly — source: publicly available supplier data. No affiliate links, no paid placement.
LL-37
Mechanism, evidence level, EU status and COA guidance per compound. No dosages, no protocols — that belongs with a doctor.